Novartis pledges to disclose data integrity issues faster; FDA uncovers “a cascade of failure” at Ipca Labs in India

#Blog

Access
All Articles

Radio Compass Blog

Novartis pledges to disclose data integrity issues faster; FDA uncovers “a cascade of failure” at Ipca Labs in India

This week, Phispers has news on Novartis, as it pledged to disclose data integrity issues within five business days to the FDA, after facing backlash over its US$ 2.1 million gene therapy — Zolgensma. The Swiss drugmaker also sold off its Chi...
2019-09-12

https://www.pharmacompass.com/radio-compass-blog/novartis-pledges-to-disclose-data-integrity-issues-faster-fda-uncovers-a-cascade-of-failure-at-ipca-labs-in-india

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1421
Share Share info
Drug mixup in Spain causes werewolf syndrome in children; explosion at plant in India kills 12

#Blog

Access
All Articles

Radio Compass Blog

Drug mixup in Spain causes werewolf syndrome in children; explosion at plant in India kills 12

This week Phispers brings news from Spain where at least 17 children developed werewolf syndrome due to a drug mix-up. Another explosion took place at a chemical plant in India last week. The chain explosion killed 12 and injured 58 people. ...
2019-09-05

https://www.pharmacompass.com/radio-compass-blog/drug-mixup-in-spain-causes-werewolf-syndrome-in-children-explosion-at-plant-in-india-kills-12

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2099
Share Share info
Explosion at Indian API manufacturer; New drug law in China; Amgen buys Celgene’s blockbuster for US$ 13.4 billion

#Blog

Access
All Articles

Radio Compass Blog

Explosion at Indian API manufacturer; New drug law in China; Amgen buys Celgene’s blockbuster for US$ 13.4 billion

This week, Celgene and BMS moved a step closer to their US$ 74 billion merger as Amgen agreed to buy Celgene’s psoriasis drug Otezla for US$ 13.4 billion. With this sale, Celgene is addressing the US competition regulator’s concerns ove...
2019-08-29

https://www.pharmacompass.com/radio-compass-blog/explosion-at-indian-api-manufacturer-new-drug-law-in-china-amgen-buys-celgene-s-blockbuster-for-us-13-4-billion

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2264
Share Share info
Novartis in crisis management mode; Elanco buys Bayer’s animal health business for US$ 7.6 billion

#Blog

Access
All Articles

Radio Compass Blog

Novartis in crisis management mode; Elanco buys Bayer’s animal health business for US$ 7.6 billion

This week, Phispers updates you on the data manipulation at Novartis for its gene therapy Zolgensma. The Swiss drugmaker is now trying to restrict the damage it has caused to the company’s image, with CEO Vas Narasimhan even admitting that the...
2019-08-22

https://www.pharmacompass.com/radio-compass-blog/novartis-in-crisis-management-mode-elanco-buys-bayer-s-animal-health-business-for-us-7-6-billion

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1859
Share Share info
FDA warning letter to Turkish firm over possible penicillin contamination of cancer drug

#Blog

Access
All Articles

Radio Compass Blog

FDA warning letter to Turkish firm over possible penicillin contamination of cancer drug

Last week, the US Food and Drug Administration (FDA) had issued a warning letter to Lantech Pharmaceuticals in India, a contract manufacturer for companies like Aurobindo Pharma, as its cleaning practices had created a potential for all products t...
2019-08-22

https://www.pharmacompass.com/radio-compass-blog/fda-warning-letter-to-turkish-firm-over-possible-penicillin-contamination-of-cancer-drug

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 747
Share Share info
US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project

#Blog

Access
All Articles

Radio Compass Blog

US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project

This week in Phispers, we bring you news about Nektar Therapeutics which disclosed declining efficacy of its lead project due to manufacturing problems. In Congo, two experimental drugs showed survival rates of nearly 90 percent in patients sufferi...
2019-08-15

https://www.pharmacompass.com/radio-compass-blog/us-senator-seeks-unannounced-fda-inspections-nektar-reports-manufacturing-issues-with-lead-project

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1513
Share Share info
Aurobindo’s contract manufacturer and Emcure receive FDA warning letters

#Blog

Access
All Articles

Radio Compass Blog

Aurobindo’s contract manufacturer and Emcure receive FDA warning letters

The US Food and Drug Administration (FDA) is continuing its in-depth investigations into the root-cause of the cancer-causing impurities that were detected in valsartan and other blood pressure medicines last year. Last month, the FDA posted a w...
2019-08-15

https://www.pharmacompass.com/radio-compass-blog/aurobindo-s-contract-manufacturer-and-emcure-receive-fda-warning-letters

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2391
Share Share info
CMOs and generic suppliers have same objective, but reach their goals differently

#Blog

Access
All Articles

Radio Compass Blog

CMOs and generic suppliers have same objective, but reach their goals differently

This week, we reconnect with Roberto Baima, operations director at PharmaChem Technologies GB Limited. While he was the quality director at Cambrex Profarmaco Milano, the Italian operations of the US-based Cambrex, he had shared a European manufact...
2019-08-08

https://www.pharmacompass.com/radio-compass-blog/cmos-and-generic-suppliers-have-same-objective-but-reach-their-goals-differently

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 790
Share Share info
FDA highlights data manipulation concerns with Novartis’ gene therapy drug

#Blog

Access
All Articles

Radio Compass Blog

FDA highlights data manipulation concerns with Novartis’ gene therapy drug

Last week, Mylan and Pfizer had announced the merger of Upjohn, Pfizer’s off-patent branded and generic established medicines business with Mylan, to create a yet to be named new global pharmaceutical company. And PharmaCompass had ...
2019-08-08

https://www.pharmacompass.com/radio-compass-blog/fda-highlights-data-manipulation-concerns-with-novartis-gene-therapy-drug

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1857
Share Share info
Amneal co-founders return to run company; Drug industry urges Canada to act on US drug import plan

#Blog

Access
All Articles

Radio Compass Blog

Amneal co-founders return to run company; Drug industry urges Canada to act on US drug import plan

This week, Phispers has news from Canada, where its drug lobby group has urged the government to take bold steps like banning drug exports so that there is no impact of America’s plans to import drugs from Canada on its citizens. Meanwhile, t...
2019-08-08

https://www.pharmacompass.com/radio-compass-blog/amneal-co-founders-return-to-run-company-drug-industry-urges-canada-to-act-on-us-drug-import-plan

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 855
Share Share info
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty